{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:36:13Z","timestamp":1774928173693,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ZGC Nephrology & Blood Purification Innovation Alliance was obtained for this study","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with kidney disease may have concurrent hypertension and infection. Dihydropyridine calcium-channel blockers (CCB) are the most popular class of antihypertensive drugs used in clinical settings and can be metabolized by cytochrome P450 isoenzyme 3A4 (CYP3A4). Voriconazole is a commonly used antifungal treatment and a CYP3A4-inhibitor. Insufficient attention to drug interactions from the concomitant use of CCB and voriconazole may result in serious adverse reactions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we report a patient with acute kidney injury on stable anti-neutrophil cytoplasm antibody associated vasculitis who developed hyperkalemia resulting in sinus arrest with junctional escape rhythm attributed to drug interactions of CCB with voriconazole. This is a very rarely reported case and may be an under-recognized complication. After continuous renal replacement therapy and changing the anti-hypertensive drugs, symptoms, and laboratory abnormalities of the patient fully recovered.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case warns us of severe consequences of drug interactions. Co-prescription of CYP3A4-inhibitors with calcium-channel blockers increases the risk of hypotension and acute kidney injury, which may further induce hyperkalemia and arrhythmia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-021-02370-6","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T13:18:52Z","timestamp":1620652732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Severe secondary hyperkalemia and arrhythmia from drug interactions between calcium\u2010channel blocker and voriconazole: a case presentation"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8904-201X","authenticated-orcid":false,"given":"Xinju","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Heung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,10]]},"reference":[{"issue":"2","key":"2370_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/j.ackd.2014.09.004","volume":"22","author":"B Horowitz","year":"2015","unstructured":"Horowitz B, Miskulin D, Zager P. Epidemiology of hypertension in CKD. Adv Chronic Kidney Dis. 2015;22(2):88\u201395.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"Suppl 1","key":"2370_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ndt\/16.suppl_1.70","volume":"16","author":"N Ridao","year":"2001","unstructured":"Ridao N, Lu\u00f1o J, Garc\u00eda de Vinuesa S, G\u00f3mez F, Tejedor A, Valderr\u00e1bano F. Prevalence of hypertension in renal disease. Nephrol Dial Transplant. 2001;16(Suppl 1):70\u20133.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"2370_CR3","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1124\/dmd.31.7.938","volume":"31","author":"KC Patki","year":"2003","unstructured":"Patki KC, Von Moltke LL, Greenblatt DJ. In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5. Drug Metab Dispos. 2003;31(7):938\u201344.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"2370_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1\u201360.","journal-title":"Clin Infect Dis"},{"key":"2370_CR5","unstructured":"VFEND (voriconazole) prescribing information. http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=618 (Accessed 18 May\u00a02020)."},{"issue":"3","key":"2370_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00228-008-0588-1","volume":"65","author":"J Kato","year":"2009","unstructured":"Kato J, Mori T, Nakamura Y, et al. Hypotension due to the drug interaction of voriconazole with eplerenone and nifedipine. Eur J Clin Pharmacol. 2009;65(3):323\u20134.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"2370_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1503\/cmaj.100702","volume":"183","author":"AJ Wright","year":"2011","unstructured":"Wright AJ, Gomes T, Mamdani MM, Horn JR, Juurlink DN. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers. CMAJ. 2011;183(3):303\u20137.","journal-title":"CMAJ"},{"issue":"12","key":"2370_CR8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.2146\/ajhp110486","volume":"69","author":"A Henneman","year":"2012","unstructured":"Henneman A, Thornby KA. Risk of hypotension with concomitant use of calcium-channel blockers and macrolide antibiotics. Am J Health Syst Pharm. 2012;69(12):1038\u201343.","journal-title":"Am J Health Syst Pharm"},{"key":"2370_CR9","doi-asserted-by":"crossref","unstructured":"Takeuchi S, Kotani Y, Tsujimoto T. Hypotension induced by the concomitant use of a calcium-channel blocker and clarithromycin. BMJ Case Rep. 2017. 2017.","DOI":"10.1136\/bcr-2016-218388"},{"issue":"13","key":"2370_CR10","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2169\/internalmedicine.56.8313","volume":"56","author":"E Mishima","year":"2017","unstructured":"Mishima E, Maruyama K, Nakazawa T, Abe T, Ito S. Acute Kidney Injury from Excessive Potentiation of Calcium-channel Blocker via Synergistic CYP3A4 Inhibition by Clarithromycin Plus Voriconazole. Intern Med. 2017;56(13):1687\u201390.","journal-title":"Intern Med"},{"issue":"7","key":"2370_CR11","doi-asserted-by":"publisher","first-page":"e116-9","DOI":"10.1002\/phar.1432","volume":"34","author":"W Jones","year":"2014","unstructured":"Jones W, Chastain CA, Wright PW. Iatrogenic cushing syndrome secondary to a probable interaction between voriconazole and budesonide. Pharmacotherapy. 2014;34(7):e116-9.","journal-title":"Pharmacotherapy"},{"issue":"4","key":"2370_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/0897190016646510","volume":"30","author":"AK Duman","year":"2017","unstructured":"Duman AK, Fulco PP. Adrenal Insufficiency With Voriconazole and Inhaled\/Intranasal Corticosteroids: Case Report and Systematic Review. J Pharm Pract. 2017;30(4):459\u201363.","journal-title":"J Pharm Pract"},{"issue":"4","key":"2370_CR13","first-page":"275","volume":"30","author":"DM Haas","year":"2013","unstructured":"Haas DM, Quinney SK, Clay JM, et al. Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic. Am J Perinatol. 2013;30(4):275\u201381.","journal-title":"Am J Perinatol"},{"issue":"9","key":"2370_CR14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.5414\/CP202211","volume":"53","author":"XF Wang","year":"2015","unstructured":"Wang XF, Yan L, Cao HM, et al. Effect of CYP3A4*1G, CYP3A5*3, POR*28, and ABCB1 C3435T on the pharmacokinetics of nifedipine in healthy Chinese volunteers. Int J Clin Pharmacol Ther. 2015;53(9):737\u201345.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"8","key":"2370_CR15","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1002\/jps.22109","volume":"99","author":"DR Luke","year":"2010","unstructured":"Luke DR, Tomaszewski K, Damle B, Schlamm HT. Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD). J Pharm Sci. 2010;99(8):3291\u2013301.","journal-title":"J Pharm Sci"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02370-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02370-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02370-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T13:37:26Z","timestamp":1620653846000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02370-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,10]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2370"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02370-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,10]]},"assertion":[{"value":"25 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was waived from ethic review under the regulatory guidance of the National Health Commission of the People\u2019s Republic of China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This 70-year-old lady is illiterate and living in a town far away from Beijing city where our hospital is based. During the COVID-19 pandemic, she was unable to come to our hospital to give her consent. Her son came to my office for outpatient consultants. The son asked for this patient\u2019s permission and signed the written informed consent for publication of this case presentation and any accompanying images on behalf of her.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}